## **Core Concept**
The Na+ - K+ pump, also known as the sodium-potassium pump, is an **enzyme** (an **ATPase**) that moves **sodium ions out** and **potassium ions into** the cell, using **energy from ATP**. This pump is crucial for maintaining the **resting potential** and **ion balance** across the cell membrane. The pump has specific binding sites for **Na+**, **K+**, and **ATP**, which are located on its **subunits**.

## **Why the Correct Answer is Right**
The Na+ - K+ pump is a **heterodimeric enzyme** composed of **α** and **β** subunits. The **α subunit** spans the membrane and has binding sites for **Na+** and **ATP**. The **β subunit** is a **glycoprotein** that is essential for the pump's **stabilization** and **function**. The binding site for **K+** is present on the **α subunit**, but **ouabain (a cardiac glycoside)**, which inhibits the pump, binds to the **β subunit** (more specifically, to the **α subunit's extracellular domain**, but its action is influenced by the **β subunit**). However, among the given options, the focus is on **ATP binding**, which primarily occurs on the **α subunit**, but in relation to **ouabain** and the **configuration** of the pump, **it relates to the pump's function influenced through the β-subunit indirectly**.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because, although **it could relate to specific sites**, without specifics, it's hard to directly refute, but generally, **Na+ binding** occurs on the **α subunit**.
- **Option B:** Incorrect as **it does not directly relate** to a commonly described **β subunit-specific ligand** or **binding site** directly; **ouabain** does interact but through effects on the **α subunit**.
- **Option C:** Incorrect because **this option** likely describes **ATP binding** or another site not specifically **attributed to the β subunit** in a direct manner; **ATP binding** primarily occurs on the **α subunit**.
- **Option D:**
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **ouabain**, a **cardiac glycoside**, inhibits the **Na+ - K+ pump**, leading to **increased intracellular Na+** and subsequently **increased intracellular Ca2+** through the **Na+/Ca2+ exchanger**, which **increases cardiac contractility**. This action is **therapeutic in heart failure** but can also be **toxic**.

## **Correct Answer:** .